Mono Pharmacare SME IPO

Mono Pharmacare Limited

₹1,04,000 /4000 sharesMinimum Investment

Mono Pharmacare SME IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
28 Aug ‘23 - 30 Aug ‘23₹1,04,0004,000₹26 - ₹28
Issue SizeIPO Doc
14.84Cr
RHP PDF

About Mono Pharmacare SME

Mono Pharmacare, incorporated in 1994, operates in the pharmaceutical industry. It specializes in the marketing and distribution of pharmaceutical products. They collaborate with contract manufacturers to produce medications according to their formulations, which are then sold under the 'DLS Export' brand. In addition to this, they serve as distributors for various pharmaceutical companies. Their product lineup includes various medicines, such as antibiotics, antifungal treatments, cold and allergy remedies, antacids, pain relievers, nutritional supplements, skin care products, antiseptics, cardiac medications, diabetic treatments, and cosmetics. Currently, the company conducts its operations exclusively in the western region of Gujarat, with a primary focus on Ahmedabad city. ;
Founded in
1994
Managing director
Mr. Panilam Lakhatariya
Parent organisation
Mono Pharmacare Limited

Strengths & Financials of Mono Pharmacare SME

Strengths
Risks
The company has an extensive product lineup encompassing various categories, including antibiotics, antifungal medications, cough-cold & anti-allergic remedies, antacid and antiemetics, analgesics and antipyretics, nutraceuticals, skincare products, antiseptic solutions, cardiac medications, diabetic treatments, and cosmetics.
As of February 28, 2023, it collaborated with pharmaceutical distributors and stockists. Additionally, the company maintains relationships with 3,036 customers and vendors, comprising both retail pharmacy stores and wholesalers.
The company sources its formulations from plants with WHO, ISO, and GMP certifications. These certified suppliers ensure the production of the products by employing high-quality ingredients and advanced methods, following pharmaceutical industry regulations and standards.

Mono Pharmacare SME Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Mono Pharmacare SME IPO

Apply asPrice bandApply upto
Regular26 - 28₹2 Lakh
High Networth Individual26 - 28₹2 - 5 Lakh
For Mono Pharmacare SME IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.4.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW